Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aptus Pharma Limited has informed the stock exchange that its Board of Directors will meet on Friday, June 12, 2026 at 4:00 p.m. at its corporate office in Rajkot, Gujarat. The main agenda is to consider raising funds by issuing equity shares or other eligible securities through a Preferential Allotment under SEBI ICDR Regulations, and to consider borrowings from banks, financial institutions, or other lenders. The Managing Director has also been authorised to identify prospective investors, allottees, and lenders. The company has closed its trading window for designated persons from June 9, 2026 (5:00 p.m.) until 48 hours after the board meeting outcome is disclosed.
Shareholders should watch for a potential equity dilution from the proposed preferential allotment and possible increase in debt, both of which could affect share value. Specific details like the fund quantum, issue price, and allottee identity will only be disclosed after the June 12 board meeting.